FDA advisory panel sees heightened risk in connection with GenAI #medtech FDA #FDA #genai #Hallucination
BioWorld News
媒体和电信
Actionable intelligence on the most innovative therapeutics and medical technologies in development
关于我们
BioWorld’s suite of news services delivers actionable intelligence on the most innovative therapeutics and medical technologies in development. With writers and editors stationed around the globe, BioWorld reports the breaking news – and provides key perspective on hundreds of therapeutics and devices in development, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. BioWorld The flagship daily biopharmaceutical news source covers the complete lifecycle of thousands of therapies in development from around the world, the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes. Includes data-rich content focused on financial and strategic trends with deep analysis that helps decision makers develop dynamic strategies. BioWorld MedTech The news source of record covering the latest advances in medical technologies from around the world ranging from actual devices, such as orthopedic implants, to digital health tools. BioWorld Science News and analysis on discovery and preclinical research to support crucial drug R&D decisions at the earliest stages. BioWorld Asia The weekly monitor of biopharmaceutical developments in the Asia-Pacific region
- 网站
-
https://www.bioworld.com/
BioWorld News的外部链接
- 所属行业
- 媒体和电信
- 规模
- 11-50 人
- 类型
- 上市公司
- 创立
- 1990
动态
-
Bridgebio, with FDA approval, faces Pfizer in ATTR BridgeBio Pfizer #ATTR #transthyretinamyloidosis BioWorld News #pharma #biotech
Bridgebio, with FDA approval, faces Pfizer in ATTR
bioworld.com
-
In muscular dystrophies, gene therapies race the clock #ASGCTBreakthroughs24 BioWorld News #preclinical #research
In muscular dystrophies, gene therapies race the clock
bioworld.com
-
Ultromics’ AI software for cardiac amyloidosis gets FDA approval #medtech Ultromics #amyloidosis FDA
Ultromics’ AI software for cardiac amyloidosis gets FDA approval
bioworld.com
-
Listen to the newest episode of the BioWorld Insider podcast: https://lnkd.in/e2EeHaPj Anette Breindl Karen Carey BioWorld News #biotech #pharma
-
Epigenetic changes linked to weight regain BioWorld News #preclinical #research
Epigenetic changes linked to weight regain
bioworld.com
-
FDA approves biliary tract cancer treatment from @jazzpharma (free w/ registration) #biotech #pharma FDA
FDA approves biliary tract cancer treatment from Jazz
bioworld.com
-
Medtronic, Tempus ALERT to disparities in valve replacement #medtech Medtronic #Medtronic Tempus AI #TempusAI #WomensHealth #CVD
Medtronic, Tempus ALERT to disparities in valve replacement
bioworld.com
-
More than 100M cells included in the human cell atlas BioWorld News #preclinical #research
More than 100M cells included in the human cell atlas
bioworld.com